1Weber D,Rankin K,Gavino M,et al.Thalidomide alone or with dexamethasone for previously untreated multiple myeloma[J].J Clin Oncol,2003,21:16-19.
2Gregory WM,Richards MA,Malpas JS.Combination chemotherapy vs.melphalan and prednisolone in the treatment of multiple myeloma:an overview of published trials[J].J Clin Oncol,1992,10:334-342.
3Palumbo A,Bringhen S,Caravita T.Oral melphalan and prednisone chemotherapy plus thalidomide compared with melphalan and prednisone alone in elderly patients with multiple myelome:randomised controlled trial[J].Lancet,2006,367:825-831.
4Kumar S,Lacy MQ,Dispenzieri A,et al.High-dose therapy and autologous stem cell transplantation for multiple myeloma poorly responsive to initial therapy[J].Bone Marrow Transplant,2004,34:161-167.
5Lee CK,Barlogie B,Munshi N,et al.DTPACE:an effective,novel combination chemotherapy with thalidomide for previously treated patients with myeloma[J].J Clin Oncol,2003,21:2732 -2739.
6Bergsagel DE,Dailey AJ,Langley GR,et al.The chemotherapy of plasma cell myeloma and the incidence of acute leukemia[J].N Engl J Med,1979,301:743 -748.
7Child JA,Morgan GJ,Davies FE,et al.Medical Research Council Adult Leukaemia Working Party.High-dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma[J].N Engl J Med,2003,348(19):1875-1883.
6Attal M, Harousseau JL, Stappa A, et al. A prospective, randomzed trial of autologous bone marrow transplantation and chemo2therapy in multiple myeloma [ J ]. N Engl J Med, 1996,335 (2) :91-97.
7Attar M,Harousseau JL, Stoppa A, et al. A prospective, high dose therapy in multiple myeloma: an updated analysis of the IFM90 protocol[ J]. Blood, 1998,92( Suppl 1 ) :418-422.
8Blade F, Sureda A, Ribera JM, et al. High dose therapy autotrans- plantation/intensification versus continued conventional treatment chemotherapy in multiple myeloma in patients responding to initial treatment chemotherapy. Results of a prospective randomized trial from the Spanish Cooperative Group PETHEMA [ J ]. Blood, 2001, 98(7) :815-819.
9Palumbo A, Bringhen S, Rus C,et al. A prospective randomized trial of intermediate dose melphalan ( 100 mg/m2 ) vs oral melphalan/ prednisone : an enterim analysis[ J]. Blood ,2001,98 (12) :849-853.
10Edward AS. Multiple myeloma,2004-one or two transplants[J]. N Eugl J Med,2003,349(26) :2551-2553.
